21.99
1.23 (5.92%)
| Previous Close | 20.76 |
| Open | 20.76 |
| Volume | 632,389 |
| Avg. Volume (3M) | 427,673 |
| Market Cap | 1,074,374,528 |
| Price / Earnings (Forward) | 185.19 |
| Price / Sales | 11.52 |
| Price / Book | 3.14 |
| 52 Weeks Range | |
| Earnings Date | 6 Aug 2026 |
| Profit Margin | -11.86% |
| Operating Margin (TTM) | -5.09% |
| Diluted EPS (TTM) | -0.190 |
| Quarterly Revenue Growth (YOY) | 29.90% |
| Total Debt/Equity (MRQ) | 7.64% |
| Current Ratio (MRQ) | 4.73 |
| Operating Cash Flow (TTM) | 14.63 M |
| Levered Free Cash Flow (TTM) | 39.10 M |
| Return on Assets (TTM) | -0.79% |
| Return on Equity (TTM) | -2.52% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Bullish | Mixed | |
| Stock | BioLife Solutions, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -3.5 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 0.5 |
| Average | -0.63 |
|
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Core |
| % Held by Insiders | 2.84% |
| % Held by Institutions | 100.53% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |